logo-large
  • Browse Categories

Publications by authors named "Prashant Gj"

Claim this Profile
T
TRC150094, a Novel Mitochondrial Modulator, Reduces Cardio-Metabolic Risk as an Add-On Treatment: a Phase-2, 24-Week, Multi-Center, Randomized, Double-Blind, Clinical Trial.
Deepa Joshi, Prashant Gj, Shohini Ghosh, Anookh Mohanan, Shashank Joshi

Diabetes Metab Syndr Obesยท February 2022


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: